MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Clinical and risk profiles of Parkinson’s disease from a large pan-India cohort: interim observations of the GAP-India study

    A. Kishore, R. Borgohain, R. Rajan, K. Divya, L. Prashanth, P. Pal, S. Mehta, H. Kumar, N. Kumar, S. Desai, R. Kamdadai, S. Krishnan, M. Chacko, M. Sharma (Kochi, India)

    Objective: To create a pan-Indian clinical repository of Parkinson’s Disease (PD). Background: The genetic risk for PD in India is unknown. The Luxembourg-German India Alliance…
  • 2022 International Congress

    Using quantitative susceptibility mapping and diffusion magnetic resonance imaging to identify structural features of early-stage Parkinson’s disease

    E. Alushaj, D. Hemachandra, N. Handfield-Jones, A. Kuurstra, R. Menon, A. Owen, A. Khan, P. Macdonald (London, Canada)

    Objective: To identify an imaging diagnostic biomarker of PD for use in clinics by applying structural magnetic resonance imaging (MRI) techniques. Background: The midbrain dopaminergic…
  • 2022 International Congress

    Women with Parkinson’s Disease (PD) and High Coffee Use Have a Shorter Time to Medication Initiation

    K. Wong, E. Brown, C. Meng, C. Tanner (San Francisco, USA)

    Objective: Investigate how coffee use prior to PD diagnosis affects medication initiation in PD. Background: Population studies show a decreased incidence of PD for men…
  • 2022 International Congress

    Risk and Protective Substances among the Parkinson Disease Patients in Palembang Municipality

    MRO. Odiesta, SM. Marisdina, EB. Bahar (Palembang, Indonesia)

    Objective: The aim of the study was to describe risks and protective consumptions and habits among the Parkinson's Disease (PD) Patients in Palembang Municipality Background:…
  • 2022 International Congress

    Open-Label, Single-Arm, Exploratory Trial of Opicapone: Status Update of the OASIS (OPICAPONE IN SLEEP DISORDER) Study

    R. Costa, J. Ferreira, D. Magalhães, J-F. Rocha, P. Soares-da-Silva (Coronado, Portugal)

    Objective: This study aims to evaluate the effects of opicapone (OPC) 50 mg treatment on sleep disorders in patients with Parkinson’s disease (PD) and ‘wearing-off’.…
  • 2022 International Congress

    The use of artificial intelligence-based chatbot in Parkinson’s disease

    G. Oyama, M. Ogawa, K. Morito, M. Kobayashi, Y. Yamada, K. Shinkawa, H. Kamo, T. Hatano, N. Hattori (Tokyo, Japan)

    Objective: This study aimed to assess the feasibility and efficacy of using an artificial intelligence-based chatbot for smile and speech in Parkinson’s disease (PD). Further,…
  • 2022 International Congress

    The role of GBA1 mutations in the relationship between GBA1 and alpha-synuclein in Parkinson disease

    L. Smith, M. Gegg, D. Chau, AHV. Schapira (London, United Kingdom)

    Objective: The aim of the study was to understand how the E326K GBA1 mutation results in an increased risk for Parkinson disease, through influencing the…
  • 2022 International Congress

    The STEPWISE Parkinson study: a Smartphone Based Exercise Solution for Patients With Parkinson’s Disease

    S. Schootemeijer, N. de Vries, E. Macklin, A. Ascherio, M. Schwarzschild, B. Bloem (Nijmegen, Netherlands)

    Objective: To investigate the feasibility of a smartphone app (STEPWISE app) to increase the physical activity level (i.e. number of steps) in people with Parkinson’s…
  • 2022 International Congress

    Understanding patient perceptions of the key components of Medication Adherence in PD: a multicenter, international study

    M. Tosin, C. Goetz, D. Hall, G. Stebbins, B. Oliveira (Chicago, USA)

    Objective: To understand how patients with Parkinson's disease (PD) and their care partners describe medication adherence. Background: Medication adherence in is a complex construct, associated…
  • 2022 International Congress

    The Complexity of Parkinson Disease Medication Regimens May Factor into Treatment Decisions: Results of a PMD Alliance Survey

    J. Farmer, C. Goas, J. Rivera, A. Mitchell, A. Merriam, N. Crouse, A. Formella (Pennington, USA)

    Objective: Identify factors affecting PwPD and CP communications with HCPs regarding dyskinesia and OFF episodes. Background: Managing Parkinson Disease (PD) requires clear and open communication…
  • « Previous Page
  • 1
  • …
  • 206
  • 207
  • 208
  • 209
  • 210
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley